FibroGen, Inc. (NASDAQ:FGEN) Q2 2025 Earnings Call Transcript

FibroGen, Inc. (NASDAQ:FGEN) Q2 2025 Earnings Call Transcript August 11, 2025

FibroGen, Inc. misses on earnings expectations. Reported EPS is $-3.38 EPS, expectations were $-2.25.

Operator: Thank you for standing by, and welcome to the FibroGen Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today’s program is being recorded. And now I’d like to introduce your host for today’s program, Gaia Shamis from LifeSci Advisors. Please go ahead.

Gaia...